🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/12/2018 | 0,5248 USD |
| 14/09/2018 | 0,4580 USD |
| 14/06/2018 | 0,4580 USD |
| 14/03/2018 | 0,4580 USD |
| 14/12/2017 | 0,4580 USD |
| 14/09/2017 | 0,4485 USD |
| 13/06/2017 | 0,4485 USD |
| 13/03/2017 | 0,4485 USD |
| 13/12/2016 | 0,4485 USD |
| 13/09/2016 | 0,4389 USD |
| 13/06/2016 | 0,4389 USD |
| 11/03/2016 | 0,4389 USD |
| 11/12/2015 | 0,4389 USD |
| 11/09/2015 | 0,4294 USD |
| 11/06/2015 | 0,4294 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/05/2019 | 77,58 | 78,19 | 77,40 | 77,45 | +0,19% | 1,02% | 6.071.588 |
| 23/05/2019 | 76,91 | 77,47 | 76,73 | 77,31 | +0,05% | 0,97% | 9.831.498 |
| 22/05/2019 | 75,72 | 77,43 | 75,68 | 77,27 | +1,86% | 2,32% | 13.491.847 |
| 21/05/2019 | 75,46 | 76,08 | 74,93 | 75,86 | +0,79% | 1,52% | 10.873.734 |
| 20/05/2019 | 74,77 | 75,64 | 74,67 | 75,27 | +0,20% | 1,30% | 8.281.191 |
| 17/05/2019 | 74,82 | 75,45 | 74,28 | 75,11 | -0,52% | 1,56% | 8.259.707 |
| 16/05/2019 | 74,21 | 76,23 | 74,17 | 75,51 | +2,04% | 2,78% | 9.910.831 |
| 15/05/2019 | 73,35 | 74,31 | 73,28 | 74,00 | +0,17% | 1,41% | 7.284.543 |
| 14/05/2019 | 74,06 | 74,50 | 73,82 | 73,87 | +0,32% | 0,93% | 8.113.826 |
| 13/05/2019 | 73,30 | 73,98 | 73,30 | 73,64 | -1,30% | 0,92% | 9.641.705 |
| 10/05/2019 | 74,50 | 74,74 | 73,29 | 74,61 | -0,18% | 1,95% | 9.027.158 |
| 09/05/2019 | 74,12 | 74,91 | 73,70 | 74,74 | +0,19% | 1,63% | 8.105.861 |
| 08/05/2019 | 74,74 | 75,11 | 74,33 | 74,60 | +0,36% | 1,03% | 10.567.508 |
| 07/05/2019 | 75,28 | 75,66 | 73,87 | 74,33 | -1,99% | 2,37% | 10.523.387 |
| 06/05/2019 | 74,93 | 76,14 | 74,71 | 75,84 | -0,65% | 1,90% | 9.906.534 |
| 03/05/2019 | 75,90 | 76,47 | 75,62 | 76,34 | +0,60% | 1,12% | 7.942.582 |
| 02/05/2019 | 75,01 | 76,17 | 75,01 | 75,88 | +1,02% | 1,55% | 11.579.142 |
| 01/05/2019 | 75,09 | 76,08 | 74,84 | 75,11 | +0,01% | 1,65% | 15.288.643 |
| 30/04/2019 | 74,01 | 75,29 | 72,52 | 75,11 | +2,51% | 3,74% | 11.269.039 |
| 29/04/2019 | 73,08 | 73,65 | 72,98 | 73,26 | +0,20% | 0,91% | 7.395.317 |
| 26/04/2019 | 73,13 | 73,46 | 72,61 | 73,12 | +0,38% | 1,17% | 8.888.193 |
| 25/04/2019 | 71,16 | 73,30 | 71,05 | 72,84 | +2,15% | 3,16% | 13.994.154 |
| 24/04/2019 | 71,31 | 71,67 | 70,59 | 71,31 | +0,17% | 1,51% | 12.779.102 |
| 23/04/2019 | 70,32 | 71,80 | 70,04 | 71,18 | +1,55% | 2,51% | 19.281.523 |
| 22/04/2019 | 69,81 | 70,43 | 69,41 | 70,10 | +0,37% | 1,46% | 14.548.441 |
| 18/04/2019 | 70,11 | 70,66 | 68,92 | 69,84 | -0,99% | 2,48% | 32.768.445 |
| 17/04/2019 | 74,06 | 74,06 | 70,37 | 70,53 | -4,69% | 4,99% | 34.181.463 |
| 16/04/2019 | 75,60 | 75,66 | 73,87 | 74,01 | -1,24% | 2,36% | 12.531.250 |
| 15/04/2019 | 75,68 | 75,85 | 74,88 | 74,93 | -1,13% | 1,29% | 13.822.491 |
| 12/04/2019 | 76,35 | 76,76 | 75,67 | 75,79 | -0,51% | 1,42% | 10.164.762 |